Meloxicam inhibits the growth of non-small cell lung cancer

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 2867-2872

  Tsubouchi, Y ^a   Mukai, S ^a   Kawahito, Y ^a   Yamada, R ^a   Kohno, M ^a   Inoue, K I ^a   Sano, H ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase 2; Growth; Lung cancer; Meloxicam; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MELOXICAM; PROSTAGLANDIN E2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; GENE EXPRESSION; GROWTH INHIBITORS; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; THIAZINES; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0033790479     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Estimates of the worldwide incidence of eighteen major cancers in 1985
2. Molecular biology of lung cancer
3. Non-small cell, lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs
4. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor (PPAR)-γ agonists through induction of apoptosis
5. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer
6. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
7. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors
8. Growth control of lung cancer by interruption of 5-Lipoxygenase-mediated growth factor signaling
9. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue
10. Mechanism of action of anti-inflammatory drugs
11. Prostaglandin endoperoxide H synthases-1 and -2
12. Inducible isoforms of cyclo-oxygenase and nitric-oxide synthase in inflammation
13. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
14. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
15. Expression of cyclooxygenase-2 in human gastric carcinoma
16. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
17. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey
18. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation
19. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
20. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
21. Expression of cyclooxygenase-2 in human prostate cancer
22. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
23. Selective inhibition of human cyclooxygenase-2 by meloxicam
24. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes
25. Meloxicam inhibits the growth of colorectal cancer cells
26. Aspirin use and reduced risk of fatal colon cancer
27. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
28. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
29. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines
30. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
31. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
32. 2 in human colon cancer cells
33. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
34. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production
35. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
36. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
37. Metabolism of arachidonic acid in human lung cancer cell lines
38. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
39. Gastrointestinal tolerability of meloxicam and piroxicam: A double-blind placebo-controlled study